€162.90
1.81%
Xetra, Sep 25, 09:00 am CEST.
ISIN
DE000A2YNT30
Symbol
ACT
Index
Sector
Industry

Alzchem Group Target price 2026 - Analyst rating & recommendation

Alzchem Group Classifications & Recommendation

Buy
85%
Hold
15%

Alzchem Group Price Target

Target Price €206.81
Price €162.90
Potential
Number of Estimates 10
10 Analysts have issued a price target Alzchem Group 2027 . The average Alzchem Group target price is €206.81. This is higher than the current stock price. The highest price target is
€268.80 65.01%
register free of charge
, the lowest is .
A rating was issued by 13 analysts: 11 Analysts recommend Alzchem Group to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Alzchem Group stock has an average upside potential 2027 of . Most analysts recommend the Alzchem Group stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million € 562.12 613.72
1.42% 9.18%
EBITDA Margin 21.30% 21.21%
10.92% 0.43%
Net Margin 11.29% 10.79%
15.70% 4.42%

9 Analysts have issued a sales forecast Alzchem Group 2026 . The average Alzchem Group sales estimate is

€614m
unlock
. This is
6.10% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€646m 11.69%
unlock
, the lowest is
€590m 1.94%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €562m 1.42%
2026
€614m 9.18%
unlock
2027
€712m 15.99%
unlock
2028
€811m 13.88%
unlock
2029
€893m 10.17%
unlock
2030
€973m 8.90%
unlock
2031
€1.0b 5.80%
unlock
2032
€1.1b 5.15%
unlock
2033
€1.1b 4.44%
unlock

8 Analysts have issued an Alzchem Group EBITDA forecast 2026. The average Alzchem Group EBITDA estimate is

€130m
unlock
. This is
1.94% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€138m 8.15%
unlock
, the lowest is
€125m 2.21%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €120m 12.50%
2026
€130m 8.69%
unlock
2027
€167m 27.98%
unlock
2028
€204m 22.34%
unlock
2029
€230m 12.77%
unlock
2030
€253m 9.95%
unlock
2031
€278m 9.88%
unlock
2032
€296m 6.74%
unlock
2033
€317m 7.02%
unlock

EBITDA Margin

2025 21.30% 10.92%
2026
21.21% 0.43%
unlock
2027
23.40% 10.33%
unlock
2028
25.14% 7.44%
unlock
2029
25.73% 2.35%
unlock
2030
25.98% 0.97%
unlock
2031
26.98% 3.85%
unlock
2032
27.39% 1.52%
unlock
2033
28.06% 2.45%
unlock

8 Alzchem Group Analysts have issued a net profit forecast 2026. The average Alzchem Group net profit estimate is

€66.2m
unlock
. This is
2.32% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€74.7m 10.23%
unlock
, the lowest is
€61.1m 9.86%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €63.5m 17.34%
2026
€66.2m 4.32%
unlock
2027
€86.1m 29.98%
unlock
2028
€110m 27.33%
unlock

Net Margin

2025 11.29% 15.70%
2026
10.79% 4.42%
unlock
2027
12.09% 12.05%
unlock
2028
13.52% 11.83%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share € 6.28 6.54
18.27% 4.14%
P/E 24.90
EV/Sales 2.73

8 Analysts have issued a Alzchem Group forecast for earnings per share. The average Alzchem Group EPS is

€6.54
unlock
. This is
2.24% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€7.38 10.31%
unlock
, the lowest is
€6.04 9.72%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €6.28 18.27%
2026
€6.54 4.14%
unlock
2027
€8.50 29.97%
unlock
2028
€10.83 27.41%
unlock

P/E ratio

Current 24.35 3.18%
2026
24.90 2.26%
unlock
2027
19.16 23.05%
unlock
2028
15.05 21.45%
unlock

Based on analysts' sales estimates for 2026, the Alzchem Group stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.89 12.02%
2026
2.73 5.62%
unlock
2027
2.35 13.78%
unlock
2028
2.07 12.19%
unlock
2029
1.87 9.23%
unlock
2030
1.72 8.17%
unlock
2031
1.63 5.48%
unlock
2032
1.55 4.90%
unlock
2033
1.48 4.25%
unlock

P/S ratio

Current 2.85 9.17%
2026
2.69 5.74%
unlock
2027
2.32 13.79%
unlock
2028
2.03 12.19%
unlock
2029
1.85 9.23%
unlock
2030
1.70 8.17%
unlock
2031
1.60 5.48%
unlock
2032
1.52 4.90%
unlock
2033
1.46 4.25%
unlock

Current Alzchem Group Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
➜
Locked
Locked Sep 15 2026
WARBURG RESEARCH GMBH
Locked
➜
Locked
Locked Sep 01 2026
JEFFERIES
Locked
➜
Locked
Locked Aug 01 2026
SPHENE CAPITAL GMBH
Locked
➜
Locked
Locked Jul 31 2026
JEFFERIES
Locked
➜
Locked
Locked Jul 08 2026
JEFFERIES
Locked
➜
Locked
Locked Jul 07 2026
WARBURG RESEARCH GMBH
Locked
➜
Locked
Locked Jul 01 2026
Analyst Rating Date
Locked
BERENBERG:
Locked
➜
Locked
Sep 15 2026
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
Sep 01 2026
Locked
JEFFERIES:
Locked
➜
Locked
Aug 01 2026
Locked
SPHENE CAPITAL GMBH:
Locked
➜
Locked
Jul 31 2026
Locked
JEFFERIES:
Locked
➜
Locked
Jul 08 2026
Locked
JEFFERIES:
Locked
➜
Locked
Jul 07 2026
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
Jul 01 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today